Scientific Reports (May 2024)

Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma

  • Patcharawadee Thongkumkoon,
  • Apiwat Sangphukieo,
  • Siripong Tongjai,
  • Pitiporn Noisagul,
  • Surasak Sangkhathat,
  • Wison Laochareonsuk,
  • Rawikant Kamolphiwong,
  • Piyaporn Budprom,
  • Pimpisa Teeyakasem,
  • Petlada Yongpitakwattana,
  • Viraporn Thepbundit,
  • Nutnicha Sirikaew,
  • Jeerawan Klangjorhor,
  • Jongkolnee Settakorn,
  • Sutpirat Moonmuang,
  • Pathacha Suksakit,
  • Arnat Pasena,
  • Jeerayut Chaijaruwanich,
  • Wilawan Yathongkhum,
  • Sivamoke Dissook,
  • Dumnoensun Pruksakorn,
  • Parunya Chaiyawat

DOI
https://doi.org/10.1038/s41598-024-60628-z
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Osteosarcoma is the most common malignant bone cancer in pediatric patients. Patients who respond poorly to chemotherapy experience worse clinical outcomes with a high mortality rate. The major challenge is the lack of effective drugs for these patients. To introduce new drugs for clinical approval, preclinical studies based on in vitro models must demonstrate the potency of the tested drugs, enabling the drugs to enter phase 1 clinical trials. Patient-derived cell culture is a promising testing platform for in vitro studies, as they more accurately recapitulate cancer states and genetic profiles compared to cell lines. In the present study, we established patient-derived osteosarcoma cells (PDC) from a patient who had previously been diagnosed with retinoblastoma. We identified a new variant of a germline mutation in the RB1 gene in the tissue of the patient. The biological effects of this PDC were studied to observe whether the cryopreserved PDC retained a feature of fresh PDC. The cryopreserved PDC preserved the key biological effects, including cell growth, invasive capability, migration, and mineralization, that define the conserved phenotypes compared to fresh PDC. From whole genome sequencing analysis of osteosarcoma tissue and patient-derived cells, we found that cryopreserved PDC was a minor population in the origin tissue and was selectively grown under the culture conditions. The cryopreserved PDC has a high resistance to conventional chemotherapy. This study demonstrated that the established cryopreserved PDC has the aggressive characteristics of osteosarcoma, in particular the chemoresistance phenotype that might be used for further investigation in the chemoresistant mechanism of osteosarcoma. In conclusion, the approach we applied for primary cell culture might be a promising method to generate in vitro models for functional testing of osteosarcoma.

Keywords